EU OK with $3.9 billion P&G deal for Merck's consumer health businessStaff Writer | August 28, 2018
EU antitrust regulators have approved Procter & Gamble’s 3.4 billion euro ($3.9 billion) acquisition of Merck KGaA’s consumer health unit, saying that they had no competition concerns.
Acquisition The takeover would add vitamin brands
The sector has undergone a wave of consolidation in recent years as companies bulk up product ranges and businesses in other markets, but the European Commission said that a preliminary review of the deal found no serious issues.
“The transaction gives rise to a limited number of horizontal overlaps for which the Commission found, following its market investigation, that sufficient competition will remain after the transaction,” the Commission said in a statement. ■